Nyxoah S.A. provided earnings guidance. Company expected a strong year-over-year growth in the first quarter, company anticipate sales to be down sequentially.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
9.98 EUR | +3.96% | -0.70% | +134.27% |
Apr. 12 | Nyxoah Names New Chief Medical Officer | MT |
Apr. 12 | Nyxoah S.A. Appoints Maurits Boon as Chief Medical Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+134.27% | 294M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+1.71% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- NYXH Stock
- News Nyxoah SA
- Nyxoah S.A. Provides Earnings Guidance for the First Quarter of 2024